AKT1 and neoplasm: The dysregulation of this pathway leads to activation of multiple downstream signalling cascades, such as PI3K/AKT, MAPK, and JAK/STAT, which provide tumour cells with increased cellular plasticity when confronted with therapeutic stress [13].